Alzheon Funding & Investors
Alzheon is an American clinical-stage biopharmaceutical company based in Framingham, Massachusetts. The company is developing medicines for patients suffering from Alzheimer's disease and other neurological and psychiatric disorders.
https://alzheon.com/Total Amount Raised: $157,204,768
Alzheon Funding Rounds
Grant
$47,000,000
Grant Investors
National Institute on Aging (NIA)Series B
$15,764,099
Series B Investors
Ally Bridge GroupSeries A
$10,000,000
Series A Investors
Ally Bridge GroupScott CohenSeries Unknown
$3,050,000
Series Unknown
$17,249,891
Series Unknown
$1,703,768
Series Unknown
$2,432,016
Grant
$47,000,000
Grant Investors
National Institute on Aging (NIA)Series B
$15,764,099
Series B Investors
Ally Bridge GroupDebt Financing
$3,100,000
Series Unknown
$17,249,891
Series Unknown
$1,703,768
Series Unknown
$2,432,016
Series D
$50,000,000
Debt Financing
$3,100,000
Debt Financing
$6,905,000
Funding info provided by Diffbot.